Which biologic is best in Crohn’s?

Infliximab is the most frequently prescribed biologic for induction and maintenance therapy in Crohn’s disease but adalimumab is just as good, say Australian researchers.

Their study of 81 patients at Melbourne’s Alfred Health found similar reductions on the Crohn’s Disease Activity Index (CDAI) in those on either drug at three and 12 months.

Both groups also had similarly reduced C

Latest

Trending